Cheung, Yin Ting
Chan, Alexandre
Charalambous, Andreas
Darling, H. S.
Eng, Lawson
Grech, Lisa
van den Hurk, Corina J. G.
Kirk, Deborah
Mitchell, Sandra A.
Poprawski, Dagmara
Rammant, Elke
Ramsey, Imogen
Fitch, Margaret I.
Chan, Raymond J. http://orcid.org/0000-0003-0248-7046
Article History
Received: 8 June 2021
Accepted: 4 September 2021
First Online: 15 September 2021
Change Date: 1 November 2021
Change Type: Update
Change Details: Updated due to the incorrect of the articlenote.
Declarations
:
: Approval was obtained from the Survey and Behavioral Research Ethics Committee of the Chinese University of Hong Kong (Hong Kong; Reference number: SBRE-18–512) and the Research Ethics Board of Edith Cowan University (Australia; Reference number: 2019–00334-WALKER).
: Completion and submission of the survey implied informed consent to participate.
: Not applicable
: Corina J. G. van den Hurk received funding on projects involving implementation of symptom monitoring in lung and renal cell cancer from Astra Zeneca, BMS Pharma, Boehringer Ingelheim, Merck, Pfizer and Ipsen. All other authors do not have any conflict of interest.
Free to read: This content has been made available to all.